newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

- Received clearance from US FDA for IND and from UK MHRA for CTA to initiate CHORD™, a global Phase 1/2 dose escalation clinical trial of DB-OTO in pediatric patients - - Plan to initiate the